新闻
1小时内
抗体药物偶联物引进/卖出
4 小时之前
Novo Nordisk enters exclusive negotiations to acquire a controlling stake in BIOCORP, to be followed by a tender offer on all remaining shares
并购
2023-06-02
细胞疗法免疫疗法ASH会议
2023-06-01
Pneumagen raises £8m to accelerate Phase 2 clinical development of Neumifil for the prevention & treatment of viral respiratory tract infections
融资
2023-06-01
融资
2023-05-31
2023-05-30
Carmot融资1.5亿美元,推进核心产品GLP-1/GIP临床开发
抗体药物偶联物细胞疗法
2023-05-25
疫苗信使RNA临床3期
2023-05-24
Novo Nordisk and Life Edit Therapeutics establish multi-target collaboration to discover and develop gene editing therapies for rare and cardiometabolic diseases
基因疗法引进/卖出
2023-05-24
突破RNA治疗限制!3亿美元A轮融资强化默沙东合作使用平台
基因疗法核酸药物信使RNA